AT Impf GmbH

Holdings MV

9.76B

Last Updated

2025-11-04

Total Holdings

Tracker Performance

AT Impf GmbH

S&P 500

Total Return

-20.26%

Annualized Return

-26.05%

1 Day Change

-0.50%

Sharpe Ratio

-0.57

Trade Updates

2025-11-04

Ticker

Name

11/04

Buy

99.49%

Fill Price --

100.00%

Ticker

Name

11/04

Sell

0.51%

Fill Price --

0.00%

Current Holdings

AT Impf GmbH maintains a prominent position in the Medical Biology sector (100.00%), which serves as the cornerstone of the portfolio. The remaining capital is allocated across other industries and other industries, balancing sector-specific growth potential with risk management.

Medical Biology

100.00%

Symbol

P&L %

Position Size

Ticker

Name

-20.42%

100.00%

Disclaimer

This simulated portfolio Tracker is based on holdings disclosed in institutional 13F filings. We select the top 20 holdings and construct a portfolio weighted by their relative proportions. Holdings beyond the top 20 are excluded, as their impact on the portfolio is minimal. Focusing on the top 20 enhances practicality and reflects the institution's stock-picking ability. The portfolio is periodically rebalanced to align with updated 13F filings. Note that 13F disclosures typically have a 45-day delay (e.g., Q2 2025 data is disclosed by mid-August). Users should consider this lag when tracking the portfolio, though institutional holdings are generally long-term, emphasizing strategic rationale behind changes. This portfolio is for illustrative purposes only and does not constitute investment advice. All investment decisions are the user's responsibility. Investing involves risks, including potential loss of principal. Past performance is not indicative of future results.

Frequently Asked Questions

How many stocks does AT Impf GmbH currently hold?

As of the latest update on 2025-11-04, the AT Impf GmbH portfolio consists of 1 individual holdings. The portfolio is actively managed to optimize strategy performance.

How has AT Impf GmbH's portfolio performed recently?

Over the recent period, AT Impf GmbH has demonstrated significant growth. The portfolio currently shows a Total Return of -20.26%, with an Annualized Return of -26.05%, outperforming standard market benchmarks.

What is the total portfolio value (AUM) of AT Impf GmbH?

The current market value of AT Impf GmbH's disclosed holdings is approximately $9.76B. This figure reflects the value of assets tracked based on their latest filing.